Mammalian viruses in human periodontitis

Oral Microbiology and Immunology

Volumn 11, Issue 6, 1996, Pages 381-386

  Contreras, A ^a,b   Slots, J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSIDAD DEL VALLE   (Colombia)

Author keywords

Crevicular fluid; Epstein Barr virus; Herpes simplex virus; Human cytomegalovirus; Human immunodeficiency virus; Periodontal disease; Polymerase chain reaction

Indexed keywords

EID: 0030422549     PISSN: 09020055     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-302X.1996.tb00199.x     Document Type: Article

References (76)

1. Aaby P, Knudsen K, Jensen TG et al. Measles incidence, vaccine efficacy, and mortality in two urban African areas with high vaccination coverage. J Infect Dis 1990; 162: 1043-1048.
2. Abramson JS, Mills EL. Depression of neutrophil function by viruses and its role in secondary microbial infections. Rev Infect Dis 1988; 10: 326-341.
3. Abramson JS, Wheeler GJ. Virus-induced neutrophil dysfunction: role in the pathogenesis of bacterial infections. Pediatr Infect Dis 1994; 3: 643-652.
4. Ahmed R, Morrison LA, Knipe DM. Persistence of viruses. In: Fields BN, Knipe DM, Howley PM, ed. Field's virology. 3rd edn. Philadelphia: Lippincott-Raven Publishers. 1996: 219-250.
5. Aitken C, Sengupta SK, Aedes C, Moss DJ, Sculley TB. Heterogeneity with the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virus. J Gen Virol 1994; 75: 95-100.
6. Amit R, Morag A, Ravid Z, Hochman N, Ehrlich J, Zakay-Rones Z. Detection of herpes simplex virus in gingival tissue. J Periodontol 1992; 63: 502-506.
7. Anusaksathien O, Dolby AE. Autoimmunity in periodontal disease. J Oral Pathol Med 1991; 20: 101-107.
8. Bakaletz LO. Viral potentiation of bacterial superinfection of the respiratory tract. Trends Microbiol 1995; 3: 110-114.
9. Bale JF, O'Neil ME, Grenier T. The interaction of murine cytomegalovirus with murine neutrophils: effect on migratory and phagocytic activities. J Leukoc Biol 1985; 38: 723-734.
10. Banks T, Rouse B. Herpesviruses-immune escape artist? Clin Infect Dis 1992; 14: 933-941.
11. Beersma MF, Bijlmakers MJ, Ploegh HL. Cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I H chains. J Immunol 1993; 151: 4455-4464.
12. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM. van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990; 28: 495-503.
13. Britt WJ, Alford CA. Cytomegalovirus. In: Fields BN, Knipe DM, Howley PM. ed. Field's virology. 3rd edn. Philadelphia: Lippincott-Raven Publishers. 1996: 2493-2524.
14. Cao M, Xiao X, Egbert B, Darragh T, Yen TS. Rapid detection of cutaneous herpes simplex virus infection with the polymerase chain reaction. J Invest Dermatol 1989; 82: 391-392.
15. Carney WP, Rubin RH, Hoffman RA, Hansen WP, Healey K, Hirch MS. Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis. J Immunol 1981; 126: 2114-2116.
16. Chonmaitree T, Owen MJ, Patel JA, Hedgpeth D, Horlick D, Howie VM. Effects of viral respiratory tract infection on outcome of acute otitis media. J Pediatr (St. Louis) 1992; 120: 856-862.
17. Dambaugh T, Hennessy K. Chamnakit L, Kieff E. U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc Natl Acad Sci USA 1984; 81: 7632-7636.
18. Dankner WM, McCutchan JA, Richman DD, Hirata K, Spector SA. Localization of human cytomegalovirus in peripheral blood leukocytes by in situ hybridization. J Infect Dis 1990; 161: 31-36.
19. Dodd CL, Winkler JR, Heinic GS, Daniels TE, Yee K, Greenspan D. Cytomegalovirus infection presenting as acute periodontal infection in a patient infected with the human immunodeficiency virus. J Clin Periodontol 1993; 20: 282-285.
20. Drew WL. Herpesviridae: Cytomegalovirus. In: Balows A, Hausler WJ, Jr Lennette EH, ed. Laboratory diagnosis of infectious diseases Principles and practice New York: Springer-Verlag, 1988; 247-260.
21. Ehrlich J, Cohen GH, Hochman N. Specific herpes simplex virus antigen in human gingiva. J Periodontol 1983; 54: 357-360.
22. Epstein JB, Sherlock CH, Wolber RA. Cytomegalovirus-induced gingivitis. Ann Intern Med 1992; 116: 1034.
23. Espy MJ, Patel R, Paya C, Smith T. Comparison of three methods for extraction of viral nucleic acids from blood cultures. J Clin Microbiol 1995; 33: 41-44.
24. Evermann JF, Derse D, Dorn P Interactions between herpesviruses and retroviruses: implications in the initiation of disease. Microb Pathog 1991; 10: 1-9.
25. Fainstein V, Musher DM, Cate TR. Bacterial adherence to pharyngeal cells during viral infection. J Infect Dis 1980; 141: 172-176.
26. Fauci AS. Immunopathogenesis of HIV infection. J Acquir Immune Defic Syndr 1993, 6: 655-662.
27. Ficarra G. Oral ulcerations in patients with HIV infection: etiology, diagnosis and management. In: Greenspan JS. Greenspan D. ed. Oral manifestations of HIV infections. Carol Stream, IL: Quintessence Publishing Co.. 1995; 205-217.
28. Flamand L, Stefanescu I, Ablashi DV, Menezes J. Activation of the Epstein-Barr virus replicative cycle by human herpes virus 6. J Virol 1993; 67. 6768-6777.
29. Geist LJ, Monick MM, Stinski MF. Hunninghake GW. The immediate early genes human cytomegalovirus upregulate tumor necrosis factor-α gene expression. J Clin Invest 1994; 93: 474-478.
30. Gerna G, Zipeto D, Percivalle E et al. Human cytomegalovirus infection of the major leukocyte subpopulations and evidence for initial viral replication in polymorphonuclear leukocytes from viremic patients. J Infect Dis 1992; 166: 1236-1244.
31. Glezen WP. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev 1982; 4: 25-44.
32. Glick M, Cleveland DB, Salkin LM, Alfaro-Miranda M, Fielding AF. Intraoral cytomegalovirus lesion and HIV-associated periodontitis in a patient with acquired immunodeficiency syndrome. Oral Surg Oral Med Oral Pathol 1991; 72: 716-720.
33. Goodson J, Tanner AC, Haffajee AD, Sornberger GC, Socransky SS. Patterns of progression and regression of advanced destructive penodontal disease. J Clin Periodontol 1982; 9: 472-481.
34. Grundy JE. Virologic and pathogenetic aspects of cytomegalovirus infection. Rev Infect Dis 1990; 12 (suppl 7): S711-S719.
35. Haakansson A, Kidd A, Wadell G, Sabharwal H, Svanborg C. Adenovirus infection enhances in vitro adherence of Streptococcus pneumoniae. Infect Immun 1994; 62: 2707-2714.
36. Halminton JR, Overall JC Jr, Glasgow LA. Synergistic effect on mortality in mice with murine cytomegalovirus and Pseudomonas aerugmosa, Staphytococcus aureus, or Candida albicans infection. Infect Immun 1976; 14: 982-989.
37. Ho WZ, Harouse JM, Rando RF, Gonczol E, Srinivasan A, Plotkin SA. Characterization of multiple molecular interactions between human cytomegalovirus (HCMV) and human immunodeficiency virus type I (HIV-1). Virology 1990; 176: 87-97.
38. Howell CL, Miller MJ, Martin WJ. Comparison of rates of virus isolation from leukocyte populations separated from blood by conventional and Ficoll-Paque/Macrodex methods. J Clin Microbiol 1979; 10: 533-537.
39. Jones AC, Freedman PD, Phelan JA, Baughman RA, Kerpel SM. Cytomegalovirus infections of the oral cavity. A report of six cases and review of the literature. Oral Surg Oral Med Oral Pathol 1993; 75: 76-85.
40. Kapasi K, Rice GPA. Cytomegalovirus infection of periphencal blood mononuclear cells: effects on interleukin-1 and 2 production and responsiveness, J Virol 1988; 62: 3603-3613.
41. Khanna R, Burrows SR, Moss DJ. Immune regulation in Epstein-Barr virus-associated diseases. Microbiol Rev 1995; 59: 387-405.
42. Klein BS, Dollete FR, Yolken RH. The role of respiratory syncytial virus and other viral pathogens in acute otitis media. J Pediatr 1982; 101: 16-20.
43. Krone WJA, Sninsky JJ, Goudsmit J. Detection and characterization of HIV-1 by polymerase chain reaction. J Acquir Immune Defic Syndr 1990; 3: 517-524.
44. Langford A, Kunze R, Timm H, Ruf B, Reichart P. Cytomegalovirus associated oral ulcerations in HIV-infected patients. J Oral Pathol Med 1990; 19: 71-76.
45. Madinier I, Doglio A, Cagnon L, Lefebvre JC, Monteil RA. Epstein-Barr virus DNA detection in gingival tissues of patients undergoing surgical extractions. Br J Oral Maxillofac Surg 1992; 30: 237-243.
46. Menezes J, Sundar SK. Ahoronheim CA. Immunosuppressive effects of Epstein-Barr virus infection. In: Gilmore N. Wainberg MA, ed. New York: Liss. 1985: 115-134.
47. Mocarsky ED Jr. Cytomegalovirus and their replication. In: Fields BN. Knipe DM, Howley PM, ed. Field's virology. 3rd edn. Philadelphia: Lippincott-Raven Publishers, 1996: 2447-2492.
48. Mustafa MM. Cytomegalovirus infection and disease in the immunocompromised host. Pediatr Infect Dis J 1994; 13: 249-259.
49. Myerson D, Hackman RC, Nelson JA, Ward DC, McDougall JK. Widespread presence of histologically occult cytomegalovirus. Hum Pathol 1984; 15: 430-439.
50. Patel J, Faden H, Shamara S, Ogra PL. Effect of respiratory syncytial virus on adherence, colonization and immunity of nontypable Haemoplulus inftuenzae: implications for otitis media Int J Pediatr Otorhinolaryngol 1992; 23: 15-23.
51. Parra B, Slots J. Detection of human viruses in periodontal pockets using polymerase chain reaction. Oral Microbiol Immunol 1996; 11: 289-293.
52. Persing DH. In vitro nucleic acid amplification techniques. In: Persing DH, Smith TF, Tenover FC, White TJ, ed. Diagnostic molecular microbiology principles and methods. Washington, DC: Am Soc Microbiol, 1993: 51-87.
53. Porter SR, Mutlu S, Scully CM. Viral infections affecting periodontal health. Periodont Clin Invest 1993, 15. 17-24
54. Pou AM, Rimell FL, Jordan JA et al. Adult respiratory papillomatosis. human papillomavirus type and viral coinfections as predictor of prognosis. Ann Otol Rhin Laryngol 1995; 104: 758-762.
55. Purtilo DT. Immunopathology of infectious mononucleosis and other complications of Epstein-Barr virus infections. In: Sommers SC, Rosen PP. ed. Pathology annual. Part I. East Norwalk. CT: Appleton-Lange. 1980: 229-253.
56. Quinn TC, Piot P, McCormick JB et al. Serologic and immunologic studies in patients with AIDS in North America and Africa. The potential role of infectious agents as cofactors in human immunodeficiency virus infection. JAMA 1987; 257: 2617-2621.
57. Rickinson AB, Kieff E, Epstein-Barr virus. In: Fields B, Knipe DM, Howley PM. ed. Field's virology. 3rd edn. Philadelphia: Lippincott-Raven Publishers. 1996: 2397-2450.
58. Rouse BT, Horohov DW. Immunosuppression in viral infections. Rev Infect Dis 1986; 8: 850-873.
59. Roux KH. Optimization and troubleshooting in PCR. In: Dieffenbach CW, Dveksler GS. ed. PCR primer, a laboratory manual. Plainview. NY: Cold Spring Harbor Laboratory Press. 1995, 53-62.
60. Rubin RH. Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect Dis 1990. 12 (suppl 7): S754-S766.
61. Ruddle NH, Li CB, Home WC et al. Mice transgenic for HTLV-I LTR-Tax exhibit tax expression in bone, skeletal alterations and high bone turnover. Virology 1993; 197: 196-204.
62. Seymour GJ, Gemmell E, Reinhardt RA. Eastcott J, Taubman MA Immunopathogenesis of chronic inflammatory periodontal disease: cellular and molecular mechanisms. J Periodont Res 1993; 28: 478-486.
63. Schooley TR, Densen HD, Felsentein D, Hirch MS. Henle E, Weitzman S. Antineutrophil antibodies in infectious mononucleosis. Am J Med 1984; 76: 85-90.
64. Smith PD, Saini SS, Raffeld M, Manischewitz JF, Wahl SM. Cytomegalovirus induction of tumor necrosis factor-α by human monocytes and mucosal macrophages. J Clin Invest 1992; 90: 1642-1648.
65. Solberg CO, Kalager T, Hill HR, Glette J. Polymorphonuclear leukocyte function in bacterial and viral infections. Scand J Infect Dis 1982; 14: 11-18.
66. Stenberg R, Thomsen D, Stinski M. Structural analysis of the major immediate early gene of human cytomegalovirus. J Virol 1984; 49: 190-199.
67. Taga H, Taga K, Wang F, Chretien J. Tosato G. Human and viral interleukin-10 in acute Epstein-Barr virus-induced infectious mononucleosis. J Infect Dis 1995, 171: 1347-1350.
68. Taylor-Wiedeman J, Sissons JGP. Borysiewicz LK, Sinclair JH. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol 1991; 72: 2059-2064.
69. Tosato G, Magrath I, Koski N, Dolley N, Blaese M. Activation of suppressor-T cells during Epstein-Barr virus-induced infectious mononucleosis. N Engl J Med 1979, 301: 1133-1137.
70. Tsurumi T, Maeno K, Nishiyama Y. Nucleotide sequence of the DNA polymerase gene of herpes simplex virus type 2 and comparison with the type 1 counterpart. Gene 1987; 52: 129-137.
71. Tyler KL, Fields BN. Pathogenesis of viral infections. In: Fields BN, Knipe DM. Howley PM. ed. Field's virology. 3rd edn. Philadelphia: Lippincott-Raven Publishers, 1996: 173-218.
72. Van Dyke TE Role of neutrophils in host defense to periodontal infections. In: Hamada S. Holt SC, McGhee JR. ed. Periodontal disease: pathogens & host immune responses. Tokyo: Quintessence Publishing Co., 1991: 251-261.
73. Waner JL. Human cytomegalovirus. In: Specter S. Bendinelli M, Friedman H, ed. Virus-induced immunosuppression. New York: Plenum Press, 1989: 101-116.
74. White DO, Fenner FJ. Mechanisms of disease production. In: White DO, Fenner FJ. ed. Medical virology. 4th edn. San Diego: Academic Press, 1994: 136-146.
75. Winston DJ, Stevens P, Lin CH, Gale RP Cytomegalovirus inhibits luminol-dependent chemiluminiscence of phagocytizing polymorphonuclear granulocytes. Clin Res 1981; 29: 398.
76. Whitley RJ. Herpes simplex viruses. In: Fields BN, Knipe DM. Howley PM. ed. Field's virology. 3rd edn. Philadelphia: Lippincott-Raven Publishers. 1996: 2297-2342.